FIELD: medicine.
SUBSTANCE: invention refers to medicine, genetic engineering and molecular biology. What is presented is a method for monitoring breast cancer in an individual. The method involves determining an expression ratio of the paired box 2 gene to beta defensin-1 gene (PAX2-to-DEFB1) in the cells produced from the individual's breast with the PAX2-to-DEFB1 expression ratio correlating with the breast conditions. What is also presented is a kit for monitoring breast cancer.
EFFECT: invention can be used in medicine in treating and monitoring cancer.
10 cl, 40 dwg, 8 tbl, 17 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHOSPHODIESTERASE 9A AS MARKER OF MALIGNANT TUMOR OF PROSTATE GLAND | 2010 |
|
RU2592668C2 |
| METHODS FOR PREDICTING PROSTATE CANCER | 2016 |
|
RU2760577C2 |
| METHOD OF SCREENING AND MONITORING CANCEROUS DISEASES AND KIT THEREFOR (VERSIONS) | 2012 |
|
RU2537263C2 |
| CANCER BIOMARKERS | 2007 |
|
RU2460075C2 |
| IDENTIFICATION OF TUMOUR-ASSOCIATED ANTIGENS FOR DIAGNOSTICS AND THERAPY | 2013 |
|
RU2644686C2 |
| IMMUNITY-INDUCING AGENT | 2012 |
|
RU2634862C2 |
| METHODS AND KITS FOR MOLECULAR SUBTYPING OF TUMORS | 2014 |
|
RU2690241C2 |
| MONOCLONAL ANTIBODIES AND ONE-CHAIN FRAGMENTS OF CELL-SURFACE PROSTATE-SPECIFIC MEMBRANE ANTIGEN ANTIBODIES | 2006 |
|
RU2458073C2 |
| IMMUNITY-INDUCING MEANS | 2012 |
|
RU2614386C2 |
| PHARMACEUTICAL COMPOSITION FOR TREATMENT AND/OR PREVENTION OF CANCER | 2011 |
|
RU2603742C2 |
